Dehydroevodiamine hydrochloride is primarily utilized in pharmacological research due to its potential therapeutic properties. It acts as an inhibitor of acetylcholinesterase (AChE), which helps preserve acetylcholine levels, contributing to its neuroprotective effects, particularly in the context of neurodegenerative diseases such as Alzheimer's. The compound exhibits anti-inflammatory and antioxidant properties, which may help in mitigating neuronal damage. Additionally, it has shown promise in enhancing cognitive functions and memory retention in preclinical studies. Research also explores its potential as an anticancer agent, with studies indicating its ability to induce apoptosis in certain cancer cell lines. Furthermore, it is investigated for its cardiovascular benefits, including vasorelaxant effects that could aid in managing hypertension, as well as potential antithrombotic properties to prevent blood clot formation. In basic science, it serves as a tool for studying cellular mechanisms and biochemical processes related to various diseases. Overall, Dehydroevodiamine hydrochloride is a compound of interest in various medical research fields, aiming to harness its biological activities for therapeutic applications.